Trinity Biotech enters $81.25 million term loan via Perceptive Advisors

By Rebecca Melvin

Concord, N.H., Jan. 28 – Trinity Biotech plc closed a $81.25 million senior secured term loan credit facility with Perceptive Advisors.

Proceeds of the loan, together with cash on hand and funds from new American Depository Shares, will be used to retire about $99.7 million of notes, according to 6-K filing with the Securities and Exchange Commission and company press release.

The notes are expected to be retired on Friday.

The new term loan is among the company’s previously announced refinancing transactions.

Perceptive is an investment manager with expertise in healthcare, according to the press release.

Trinity Biotech is a developer and marketer of diagnostic systems based in Dublin.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.